Encouraging Phase 2 HIT data and recent FDA feedback support continued advancement of CAD-1005 as Cadrenal’s near-term development priority; broader 12-LOX platform remains a longer-term opportunity ...
Jiayin Group Inc. ('Jiayin” or the 'Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its ...
Meesho is well placed to benefit from e-commerce growth driven by rising tier 2 penetration, leveraging its value play and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results